Skip to main content
Defiance International

Published study records

Study records for Humanin

Study records describe published research and its limitations. They do not establish efficacy, safety, or suitability for any use.

Study record counts

449 study records.

49 evidence-verified · 299 citation-verified · 95 identifier-confirmed · 6 citation-only

Listed by tier, then records with a public summary first, then publication year, newest first, undated last.

Verified records by research setting

  • In vitro: 129
  • In vivo/preclinical: 133
  • Review/meta-analysis: 38
  • Other: 0
Filter study recordsReset filters

Filtered results

Study type: In vivo/preclinical · Verification: Citation only

  • 2026

Humanin Restores Metabolic Hormone Homeostasis of Leptin, Ghrelin, Irisin and Asprosin in Streptozotocin-Induced Diabetic Mice

Metabolites · 2026

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.

Study type: In vitro · Verification: Citation only

  • 2026

Humanin improved the rotenone-induced reactive oxygen species formation in PC12 cells by modulating the SIRT3/Nrf2/HO-1 signaling pathway

Toxicology and Industrial Health · 2026

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.

Study type: Human research · Verification: Citation only

  • 2026

Mediterranean diet adherence is associated with mitochondrial microproteins Humanin and SHMOOSE; potential role of the Humanin–Nox2 interaction in cardioprotection

Frontiers in Nutrition · 2026

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.

Study type: In vivo/preclinical · Verification: Citation only

  • 2018

Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice

American Journal of Physiology-Heart and Circulatory Physiology · 2018

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.

Study type: In vitro · Verification: Citation only

  • 2013

Amelioration of neurodegenerative diseases by cell death-induced cytoplasmic delivery of humanin

Journal of Controlled Release · 2013

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.